Background: There are two main myocardial metabolic pathways including glucose oxidative pathway and free fatty acid (FFA) oxidative pathway. FFA is the major source of energy for the heart, generating 60% to 90% of energy while glucose metabolism produces the rest 10% to 40% of energy depending on physiological conditions. Objective: This study was carried out to observe the intensity and to analyze the differences in the intensity of 18F-FDG uptake in the wall of LV WITH and WITHOUT oral ingestion of edible oils during whole body (WB) 18F-FDG PET/CT study. Methodology: This is a prospective study involving patients undergoing modified WB 18F-FDG PET/CT protocol; [Group A (n=12) : WB + oral ingestion of 50ml virgin coconut oil (VCO); Group...
Introduction: Adequate suppression of physiologic myocardial glucose uptake is important to ensure t...
To test the ability of ketone bodies to inhibit myocardial fatty acid oxidation in vivo, the myocard...
We have evaluated whether myocardial uptake of the fatty acid analog 123I-15-(p-iodophenyl)-3-R,S-me...
Background: There are two main myocardial metabolic pathways including glucose oxidative pathway and...
Low-carbohydrate (LC) and high-fat, low-carbohydrate (HFLC) dietary preparations may enhance 18F-FDG...
Background: 18F-FDG PET/CT is a promising method for imaging coronary atherosclerotic plaque inflamm...
AbstractObjectives18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomograph...
Impaired cardiac systolic and diastolic function has been observed in preclinical models and in subj...
Altered myocardial fuel selection likely underlies cardiac disease risk in diabetes, affecting oxyge...
BACKGROUND & AIMS: Hepatic lipotoxicity results from and contributes to obesity-related disorders. I...
Background: 18F-FDG-PET/CT is a promising approach for imaging atherosclerotic plaque inflammation. ...
BACKGROUND & AIMS: Hepatic lipotoxicity results from and contributes to obesity-related disorders. I...
BACKGROUND and AIMS: Hepatic lipotoxicity results from and contributes to obesity-related disorders....
Background: 18F-fluorodeoxyglucose (FDG) PET/CT plays an important role to detect active cardiac inv...
Introduction: Despite the decades long use of [ 11 C]palmitate positron emission tomography (PET)/co...
Introduction: Adequate suppression of physiologic myocardial glucose uptake is important to ensure t...
To test the ability of ketone bodies to inhibit myocardial fatty acid oxidation in vivo, the myocard...
We have evaluated whether myocardial uptake of the fatty acid analog 123I-15-(p-iodophenyl)-3-R,S-me...
Background: There are two main myocardial metabolic pathways including glucose oxidative pathway and...
Low-carbohydrate (LC) and high-fat, low-carbohydrate (HFLC) dietary preparations may enhance 18F-FDG...
Background: 18F-FDG PET/CT is a promising method for imaging coronary atherosclerotic plaque inflamm...
AbstractObjectives18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomograph...
Impaired cardiac systolic and diastolic function has been observed in preclinical models and in subj...
Altered myocardial fuel selection likely underlies cardiac disease risk in diabetes, affecting oxyge...
BACKGROUND & AIMS: Hepatic lipotoxicity results from and contributes to obesity-related disorders. I...
Background: 18F-FDG-PET/CT is a promising approach for imaging atherosclerotic plaque inflammation. ...
BACKGROUND & AIMS: Hepatic lipotoxicity results from and contributes to obesity-related disorders. I...
BACKGROUND and AIMS: Hepatic lipotoxicity results from and contributes to obesity-related disorders....
Background: 18F-fluorodeoxyglucose (FDG) PET/CT plays an important role to detect active cardiac inv...
Introduction: Despite the decades long use of [ 11 C]palmitate positron emission tomography (PET)/co...
Introduction: Adequate suppression of physiologic myocardial glucose uptake is important to ensure t...
To test the ability of ketone bodies to inhibit myocardial fatty acid oxidation in vivo, the myocard...
We have evaluated whether myocardial uptake of the fatty acid analog 123I-15-(p-iodophenyl)-3-R,S-me...